Šimons Svirskis

728 total citations
56 papers, 536 citations indexed

About

Šimons Svirskis is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases. According to data from OpenAlex, Šimons Svirskis has authored 56 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 8 papers in Infectious Diseases. Recurrent topics in Šimons Svirskis's work include Neuroscience and Neuropharmacology Research (7 papers), Biochemical Analysis and Sensing Techniques (6 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). Šimons Svirskis is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Biochemical Analysis and Sensing Techniques (6 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). Šimons Svirskis collaborates with scholars based in Latvia, Sweden and Russia. Šimons Svirskis's co-authors include Vija Kluša, Modra Murovska, Juris Rumaks, Sergejs Isajevs, Jolanta Pupure, Ivars Kalvinsh, Angelika Krūmiņa, Zaiga Nora-Krūkle, Jarl E. S. Wikberg and Olga Stephansson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Šimons Svirskis

53 papers receiving 526 citations

Peers

Šimons Svirskis
Bryan Knipe United States
W. E. Scales United States
Juliana I. Sesma United States
Iveta Grants United States
Katie B. Freeman United States
Šimons Svirskis
Citations per year, relative to Šimons Svirskis Šimons Svirskis (= 1×) peers Reiko Ichikawa

Countries citing papers authored by Šimons Svirskis

Since Specialization
Citations

This map shows the geographic impact of Šimons Svirskis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Šimons Svirskis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Šimons Svirskis more than expected).

Fields of papers citing papers by Šimons Svirskis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Šimons Svirskis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Šimons Svirskis. The network helps show where Šimons Svirskis may publish in the future.

Co-authorship network of co-authors of Šimons Svirskis

This figure shows the co-authorship network connecting the top 25 collaborators of Šimons Svirskis. A scholar is included among the top collaborators of Šimons Svirskis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Šimons Svirskis. Šimons Svirskis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Svirskis, Šimons, et al.. (2023). Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression. Frontiers in Immunology. 14. 1294758–1294758. 4 indexed citations
5.
Svirskis, Šimons, Santa Rasa, Zaiga Nora-Krūkle, et al.. (2022). Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in Immunology. 13. 928945–928945. 28 indexed citations
6.
Krūmiņa, Angelika, et al.. (2021). Clinical Profile and Aspects of Differential Diagnosis in Patients with ME/CFS from Latvia. Medicina. 57(9). 958–958. 11 indexed citations
7.
Nora-Krūkle, Zaiga, et al.. (2021). Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Biomolecules. 11(8). 1189–1189. 8 indexed citations
8.
Tretjakovs, Pēteris, et al.. (2021). Thioredoxin-1 and Correlations of the Plasma Cytokines Regarding Aortic Valve Stenosis Severity. Biomedicines. 9(8). 1041–1041. 6 indexed citations
9.
Nora-Krūkle, Zaiga, et al.. (2019). Cytokines and MMP-9 Levels in Rheumatoid Arthritis and Osteoarthritis Patients with Persistent Parvovirus B19, HHV-6 and HHV-7 Infection. Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences. 73(4). 278–287. 2 indexed citations
10.
Krūmiņa, Angelika, et al.. (2019). Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance. Medicina. 55(2). 33–33. 12 indexed citations
11.
Krūmiņa, Angelika, Svetlana Chapenko, Marija Mihailova, et al.. (2019). The role of HHV-6 and HHV-7 infections in the development of fibromyalgia. Journal of NeuroVirology. 25(2). 194–207. 13 indexed citations
12.
Svirskis, Šimons, et al.. (2018). Characterisation and In Vivo Safety of Canine Adipose-Derived Stem Cells. Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences. 72(3). 160–171.
13.
Hägglund, Maria, Sonchita Bagchi, Victor C. Nilsson, et al.. (2013). Characterization of the transporterB0AT3 (Slc6a17) in the rodent central nervous system. BMC Neuroscience. 14(1). 54–54. 17 indexed citations
14.
Pupure, Jolanta, Sergejs Isajevs, Elina Skapare, et al.. (2009). Neuroprotective properties of mildronate, a mitochondria-targeted small molecule. Neuroscience Letters. 470(2). 100–105. 25 indexed citations
15.
Pupure, Jolanta, Sergejs Isajevs, Immanuels Taivāns, et al.. (2008). Distinct Influence of Atypical 1,4‐Dihydropyridine Compounds in Azidothymidine‐Induced Neuro‐ and Cardiotoxicity in Mice Ex Vivo. Basic & Clinical Pharmacology & Toxicology. 103(5). 401–406. 7 indexed citations
16.
Sundberg, Björn, Josefin A. Jacobsson, Olga Stephansson, et al.. (2008). The Evolutionary History and Tissue Mapping of Amino Acid Transporters Belonging to Solute Carrier Families SLC32, SLC36, and SLC38. Journal of Molecular Neuroscience. 35(2). 179–193. 72 indexed citations
17.
Jansone, Baiba, Lena Bergström, Šimons Svirskis, et al.. (2004). Opposite effects of γ1- and γ2-melanocyte stimulating hormone on regulation of the dopaminergic mesolimbic system in rats. Neuroscience Letters. 361(1-3). 68–71. 16 indexed citations
18.
Kluša, Vija, S. K. Germane, Šimons Svirskis, & Jarl E. S. Wikberg. (2001). The g2-MSH peptide mediates a central analgesic effect via a GABA-ergic mechanism that is independent from activation of melanocortin receptors. Neuropeptides. 35(1). 50–57. 15 indexed citations
20.
Kluša, Vija, Raul‐Allan Kiivet, Ruta Muceniece, et al.. (1990). Thymopentin antagonizes stress-induced changes of GABA/benzodiazepine receptor complex. Regulatory Peptides. 27(3). 355–365. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026